Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:51 UTC |
---|
HMDB ID | HMDB0015064 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Misoprostol |
---|
Description | Misoprostol is only found in individuals that have used or taken this drug. It is a synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. [PubChem]Misoprostol seems to inhibit gastric acid secretion by a direct action on the parietal cells through binding to the prostaglandin receptor. The activity of this receptor is mediated by G proteins which normally activate adenylate cyclase. The indirect inhibition of adenylate cyclase by Misoprostol may be dependent on guanosine-5’-triphosphate (GTP). The significant cytoprotective actions of misoprostol are related to several mechanisms. These include: 1. Increased secretion of bicarbonate, 2. Considerable decrease in the volume and pepsin content of the gastric secretions, 3. It prevents harmful agents from disrupting the tight junctions between the epithelial cells which stops the subsequent back diffusion of H+ ions into the gastric mucosa, 4. Increased thickness of mucus layer, 5. Enhanced mucosal blood flow as a result of direct vasodilatation, 6. Stabilization of tissue lysozymes/vascular endothelium, 7. Improvement of mucosal regeneration capacity, and 8. Replacement of prostaglandins that have been depleted as a result of various insults to the area. Misoprostol has also been shown to increase the amplitude and frequency of uterine contractions during pregnancy via selective binding to the EP-2/EP-3 prostanoid receptors. |
---|
Structure | CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC InChI=1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1 |
---|
Synonyms | Value | Source |
---|
Cytotec | Kegg | Apo-misoprostol | HMDB | Apotex brand OF misoprostol | HMDB | Glefos | HMDB | Misoprostol pfizer brand | HMDB | Misoprostol, (11alpha,13E,16R)-isomer | HMDB | Misoprostol, (11alpha.13E,16S)-isomer | HMDB | Misoprostol, (11beta,13E,16S)-isomer | HMDB | Apo misoprostol | HMDB | Grunenthal brand OF misoprostol | HMDB | Misoprostol grunenthal brand | HMDB | Misoprostol novopharm brand | HMDB | Misoprostol, (11alpha,13Z)-(+-)-isomer | HMDB | Misoprostol, (11beta,13E,16R)-isomer | HMDB | Misoprostol apotex brand | HMDB | Misoprostol, (11alpha,13E)-isomer | HMDB | Misoprostol, (11beta,13E)-(+-)-isomer | HMDB | Novo misoprostol | HMDB | Novo-misoprostol | HMDB | Novopharm brand OF misoprostol | HMDB | Pfizer brand OF misoprostol | HMDB |
|
---|
Chemical Formula | C22H38O5 |
---|
Average Molecular Weight | 382.5341 |
---|
Monoisotopic Molecular Weight | 382.271924326 |
---|
IUPAC Name | methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate |
---|
Traditional Name | misoprostol |
---|
CAS Registry Number | 59122-46-2 |
---|
SMILES | CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC |
---|
InChI Identifier | InChI=1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1 |
---|
InChI Key | OJLOPKGSLYJEMD-URPKTTJQSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Prostaglandins and related compounds |
---|
Alternative Parents | |
---|
Substituents | - Prostaglandin skeleton
- Fatty acid ester
- Fatty acid methyl ester
- Cyclopentanol
- Cyclic alcohol
- Tertiary alcohol
- Methyl ester
- Secondary alcohol
- Ketone
- Carboxylic acid ester
- Cyclic ketone
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Alcohol
- Carbonyl group
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.016 g/L | Not Available | LogP | 3.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Misoprostol,1TMS,isomer #1 | CCCCC(C)(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C | 2818.4 | Semi standard non polar | 33892256 | Misoprostol,1TMS,isomer #2 | CCCCC(C)(O)C/C=C/[C@H]1[C@H](O[Si](C)(C)C)CC(=O)[C@@H]1CCCCCCC(=O)OC | 2732.1 | Semi standard non polar | 33892256 | Misoprostol,1TMS,isomer #3 | CCCCC(C)(O)C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C)C[C@H]1O | 2817.4 | Semi standard non polar | 33892256 | Misoprostol,1TMS,isomer #4 | CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)C=C(O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)OC | 2741.8 | Semi standard non polar | 33892256 | Misoprostol,2TMS,isomer #1 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C)CC(=O)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C | 2786.7 | Semi standard non polar | 33892256 | Misoprostol,2TMS,isomer #2 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C)C[C@H]1O)O[Si](C)(C)C | 2891.5 | Semi standard non polar | 33892256 | Misoprostol,2TMS,isomer #3 | CCCCC(C)(C/C=C/[C@H]1[C@H](O)C=C(O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C | 2815.3 | Semi standard non polar | 33892256 | Misoprostol,2TMS,isomer #4 | CCCCC(C)(O)C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C | 2794.9 | Semi standard non polar | 33892256 | Misoprostol,2TMS,isomer #5 | CCCCC(C)(O)C/C=C/[C@H]1[C@H](O[Si](C)(C)C)C=C(O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)OC | 2772.8 | Semi standard non polar | 33892256 | Misoprostol,3TMS,isomer #1 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 2869.0 | Semi standard non polar | 33892256 | Misoprostol,3TMS,isomer #1 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 2858.2 | Standard non polar | 33892256 | Misoprostol,3TMS,isomer #1 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 3028.9 | Standard polar | 33892256 | Misoprostol,3TMS,isomer #2 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C)C=C(O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C | 2856.3 | Semi standard non polar | 33892256 | Misoprostol,3TMS,isomer #2 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C)C=C(O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C | 2708.3 | Standard non polar | 33892256 | Misoprostol,3TMS,isomer #2 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C)C=C(O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C | 3111.1 | Standard polar | 33892256 | Misoprostol,1TBDMS,isomer #1 | CCCCC(C)(C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C(C)(C)C | 3059.9 | Semi standard non polar | 33892256 | Misoprostol,1TBDMS,isomer #2 | CCCCC(C)(O)C/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)CC(=O)[C@@H]1CCCCCCC(=O)OC | 2945.9 | Semi standard non polar | 33892256 | Misoprostol,1TBDMS,isomer #3 | CCCCC(C)(O)C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C(C)(C)C)C[C@H]1O | 3033.5 | Semi standard non polar | 33892256 | Misoprostol,1TBDMS,isomer #4 | CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)C=C(O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)OC | 2970.5 | Semi standard non polar | 33892256 | Misoprostol,2TBDMS,isomer #1 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)CC(=O)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C(C)(C)C | 3242.5 | Semi standard non polar | 33892256 | Misoprostol,2TBDMS,isomer #2 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C(C)(C)C)C[C@H]1O)O[Si](C)(C)C(C)(C)C | 3339.9 | Semi standard non polar | 33892256 | Misoprostol,2TBDMS,isomer #3 | CCCCC(C)(C/C=C/[C@H]1[C@H](O)C=C(O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C(C)(C)C | 3268.3 | Semi standard non polar | 33892256 | Misoprostol,2TBDMS,isomer #4 | CCCCC(C)(O)C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C | 3235.5 | Semi standard non polar | 33892256 | Misoprostol,2TBDMS,isomer #5 | CCCCC(C)(O)C/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C=C(O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)OC | 3225.1 | Semi standard non polar | 33892256 | Misoprostol,3TBDMS,isomer #1 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3523.7 | Semi standard non polar | 33892256 | Misoprostol,3TBDMS,isomer #1 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3327.9 | Standard non polar | 33892256 | Misoprostol,3TBDMS,isomer #1 | CCCCC(C)(C/C=C/[C@@H]1C(CCCCCCC(=O)OC)=C(O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3241.1 | Standard polar | 33892256 | Misoprostol,3TBDMS,isomer #2 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C=C(O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C(C)(C)C | 3523.9 | Semi standard non polar | 33892256 | Misoprostol,3TBDMS,isomer #2 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C=C(O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C(C)(C)C | 3059.4 | Standard non polar | 33892256 | Misoprostol,3TBDMS,isomer #2 | CCCCC(C)(C/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C=C(O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)OC)O[Si](C)(C)C(C)(C)C | 3278.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Misoprostol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0zgl-7669000000-5ba5f8c705e7fe123902 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Misoprostol GC-MS (2 TMS) - 70eV, Positive | splash10-03di-8401960000-4f4e8e532189a747dc22 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Misoprostol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 10V, Positive-QTOF | splash10-015a-0009000000-c605e40ea4ceb467e6ed | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 20V, Positive-QTOF | splash10-05ng-5279000000-ca00a188c62568615a83 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 40V, Positive-QTOF | splash10-0006-9320000000-392c189929e030f4922b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 10V, Negative-QTOF | splash10-001i-0009000000-9a82f88089f5b6631e26 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 20V, Negative-QTOF | splash10-01q9-1019000000-8d92776885f140f8b37d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 40V, Negative-QTOF | splash10-05fu-9544000000-f3c86ea095acacec08ba | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 10V, Positive-QTOF | splash10-00l2-0019000000-a30a015b55a7d64d4e49 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 20V, Positive-QTOF | splash10-0002-9376000000-a19eba8dafb15c38a80a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 40V, Positive-QTOF | splash10-052e-7900000000-ae532ea752261cff1c63 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 10V, Negative-QTOF | splash10-03e9-0009000000-9a1f646784188d0f175d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 20V, Negative-QTOF | splash10-01pk-0029000000-7b266207147b4e586bdc | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Misoprostol 40V, Negative-QTOF | splash10-0ufv-8689000000-1772fe79b59691de0087 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Rocha J: Brazil investigates drug's possible link with birth defects. BMJ. 1994 Sep 24;309(6957):757-8. [PubMed:7950553 ]
- Costa SH, Vessey MP: Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet. 1993 May 15;341(8855):1258-61. [PubMed:8098402 ]
- Coelho HL, Teixeira AC, Cruz Mde F, Gonzaga SL, Arrais PS, Luchini L, La Vecchia C, Tognoni G: Misoprostol: the experience of women in Fortaleza, Brazil. Contraception. 1994 Feb;49(2):101-10. [PubMed:8143449 ]
- Barbosa RM, Arilha M: The Brazilian experience with Cytotec. Stud Fam Plann. 1993 Jul-Aug;24(4):236-40. [PubMed:8212093 ]
- Gonzalez CH, Vargas FR, Perez AB, Kim CA, Brunoni D, Marques-Dias MJ, Leone CR, Correa Neto J, Llerena Junior JC, de Almeida JC: Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet. 1993 Aug 1;47(1):59-64. [PubMed:8368254 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|